Nadezhda Popova

Dr. Nadezhda Popova


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2022 in Cancers
Verified
Journal Article
Open access
PDF file
NPNadezhda Popova
Nadezhda Popova
MJManfred Jücker
Manfred Jücker
The extracellular matrix (ECM) is highly dynamic as it is constantly deposited, remodeled and degraded to maintain tissue homeostasis. ECM is a major structural component of the tumor microenvironment, and cancer development and progression require its extensive reorganization. Cancerized ECM is biochemically different in its composition and is stiffer compared to normal ECM. The abnormal ECM affects cancer progression by directly promoting cell proliferation, survival, migration and differentiation. The restructured extracellular matrix and its degradation fragments (matrikines) also modulate the signaling cascades mediated by the interaction with cell-surface receptors, deregulate the stromal cell behavior and lead to emergence of an oncogenic microenvironment. Here, we summarize the current state of understanding how the composition and structure of ECM changes during cancer progression. We also describe the functional role of key proteins, especially tenascin C and fibronectin, and signaling molecules involved in the formation of the tumor microenvironment, as well as the signaling pathways that they activate in cancer cells.

Verified
Journal Article
Open access
PDF file
NPNadezhda Popova
Nadezhda Popova
MJManfred Jücker
Manfred Jücker
The aim of this review was to summarize current available information about the role of phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling in cancer as a potential target for new therapy options. The mTOR and PI3K/AKT/mTORC1 (mTOR complex 1) signaling are critical for the regulation of many fundamental cell processes including protein synthesis, cell growth, metabolism, survival, catabolism, and autophagy, and deregulated mTOR signaling is implicated in cancer, metabolic dysregulation, and the aging process. In this review, we summarize the information about the structure and function of the mTOR pathway and discuss the mechanisms of its deregulation in human cancers including genetic alterations of PI3K/AKT/mTOR pathway components. We also present recent data regarding the PI3K/AKT/mTOR inhibitors in clinical studies and the treatment of cancer, as well the attendant problems of resistance and adverse effects.

1 June 2011 in Cell Metabolism
Verified
Journal Article
Closed access
Igor E DeyevIgor E Deyev
Igor E Deyev
FSFabien Sohet
Fabien Sohet
KVKonstantin P. Vassilenko
Konstantin P. Vassilenko
OSOksana Serova
Oksana Serova
NPNadezhda Popova
Nadezhda Popova
APAlexander G. Petrenko
Alexander G. Petrenko

15 September 2013 in Acta Naturae
Verified
Journal Article
Open access
NPNadezhda Popova
Nadezhda Popova
Igor E DeyevIgor E Deyev
Igor E Deyev
APA. G. Petrenko
A. G. Petrenko
Macromolecules gain access to the cytoplasm of eukaryotic cells using one of several ways of which clathrin-dependent endocytosis is the most researched. Although the mechanism of clathrin-mediated endocytosis is well understood in general, novel adaptor proteins that play various roles in ensuring specific regulation of the mentioned process are being discovered all the time. This review provides a detailed account of the mechanism of clathrin-mediated internalization of activated G protein-coupled receptors, as well as a description of the major proteins involved in this process.

15 December 2016 in Acta Naturae
Verified
Journal Article
Open access
VMVladimir I. Martynov
Vladimir I. Martynov
APA. A. Pakhomov
A. A. Pakhomov
NPNadezhda Popova
Nadezhda Popova
Igor E DeyevIgor E Deyev
Igor E Deyev
APA. G. Petrenko
A. G. Petrenko
The last decade has witnessed significant advance in the imaging of living systems using fluorescent markers. This progress has been primarily associated with the discovery of different spectral variants of fluorescent proteins. However, the fluorescent protein technology has its own limitations and, in some cases, the use of low-molecular-weight fluorophores is preferable. In this review, we describe the arsenal of synthetic fluorescent tools that are currently in researchers hands and span virtually the entire spectrum, from the UV to visible and, further, to the near-infrared region. An overview of recent advances in site-directed introduction of synthetic fluorophores into target cellular objects is provided. Application of these fluorescent probes to the solution of a wide range of biological problems, in particular, to the determination of local ion concentrations and pH in living systems, is discussed.

15 September 2008 in BMC Biochemistry
Verified
Journal Article
Open access
PDF file
KCKonstantin G Chernov
Konstantin G Chernov
AMAlain Mechulam
Alain Mechulam
NPNadezhda Popova
Nadezhda Popova
DPDavid Pastre
David Pastre
ENElena Nadezhdina
Elena Nadezhdina
PCPatrick Curmi
Patrick Curmi
Background: YB-1 is a major regulator of gene expression in eukaryotic cells. In addition to its role in transcription, YB-1 plays a key role in translation and stabilization of mRNAs. Results: We show here that YB-1 interacts with tubulin and microtubules and stimulates microtubule assembly in vitro. High resolution imaging via electron and atomic force microscopy revealed that microtubules assembled in the presence of YB-1 exhibited a normal single wall ultrastructure and indicated that YB-1 most probably coats the outer microtubule wall. Furthermore, we found that YB-1 also promotes the assembly of MAPs-tubulin and subtilisin-treated tubulin. Finally, we demonstrated that tubulin interferes with RNA:YB-1 complexes. Conclusion: These results suggest that YB-1 may regulate microtubule assembly in vivo and that its interaction with tubulin may contribute to the control of mRNA translation.